retatrutide 2 months vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness AmDiabetesAssn @ADA_DiabetesPro And the summary

Educating patients about the purpose, function, and proper use of CGMS empowers them to actively participate in their diabetes management and make informed decisions based on the collected data

Adjust nutrition and exercise as your weight changes

However, retatrutide has not yet received regulatory approval from the MHRA, EMA, or FDA, meaning no licensed dosage currently exists

Weight loss in particular, but also cardiorenal benefits and other potential advantages, have encouraged wider use, and several further GLP-1RAs with ever longer circulating half-lives are advancing in development, aiming to leverage the convenience of administration with minimal gastrointestinal side effects (Table 2) [37]